• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双相情感障碍患病率:文献的系统评价与荟萃分析

Bipolar disorder prevalence: a systematic review and meta-analysis of the literature.

作者信息

Clemente Adauto S, Diniz Breno S, Nicolato Rodrigo, Kapczinski Flavio P, Soares Jair C, Firmo Josélia O, Castro-Costa Érico

机构信息

Fundação Oswaldo Cruz, Belo Horizonte, MG, Brazil.

Department of Mental Health, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.

出版信息

Braz J Psychiatry. 2015 Apr-Jun;37(2):155-61. doi: 10.1590/1516-4446-2012-1693. Epub 2015 May 1.

DOI:10.1590/1516-4446-2012-1693
PMID:25946396
Abstract

OBJECTIVE

Bipolar disorder (BD) is common in clinical psychiatric practice, and several studies have estimated its prevalence to range from 0.5 to 5% in community-based samples. However, no systematic review and meta-analysis of the prevalence of BD type 1 and type 2 has been published in the literature. We carried out a systematic review and meta-analysis of the lifetime and 1-year prevalence of BD type 1 and type 2 and assessed whether the prevalence of BD changed according to the diagnostic criteria adopted (DSM-III, DSM-III-R vs. DSM-IV).

METHODS

We searched MEDLINE, Scopus, Web of Science, PsycINFO, and the reference lists of identified studies. The analyses included 25 population- or community-based studies and 276,221 participants.

RESULTS

The pooled lifetime prevalence of BD type 1 was 1.06% (95% confidence interval [95%CI] 0.81-1.31) and that of BD type 2 was 1.57% (95%CI 1.15-1.99). The pooled 1-year prevalence was 0.71% (95%CI 0.56-0.86) for BD type 1 and 0.50% (95%CI 0.35-0.64) for BD type 2. Subgroup analysis showed a significantly higher lifetime prevalence of BD type 1 according to the DSM-IV criteria compared to the DSM-III and DSM-IIIR criteria (p < 0.001).

CONCLUSION

This meta-analysis confirms that estimates of BD type 1 and type 2 prevalence are low in the general population. The increase in prevalence from DSM-III and DSM-III-R to DSM-IV may reflect different factors, such as minor changes in diagnostic operationalization, use of different assessment instruments, or even a genuine increase in the prevalence of BD.

摘要

目的

双相情感障碍(BD)在临床精神科实践中很常见,多项研究估计其在社区样本中的患病率为0.5%至5%。然而,文献中尚未发表关于1型和2型双相情感障碍患病率的系统评价和荟萃分析。我们对1型和2型双相情感障碍的终生患病率和1年患病率进行了系统评价和荟萃分析,并评估了双相情感障碍的患病率是否根据所采用的诊断标准(DSM-III、DSM-III-R与DSM-IV)而有所变化。

方法

我们检索了MEDLINE、Scopus、科学引文索引、PsycINFO以及已识别研究的参考文献列表。分析纳入了25项基于人群或社区的研究以及276,221名参与者。

结果

1型双相情感障碍的合并终生患病率为1.06%(95%置信区间[95%CI]0.81-1.31),2型双相情感障碍的合并终生患病率为1.57%(95%CI 1.15-1.99)。1型双相情感障碍的合并1年患病率为0.71%(95%CI 0.56-0.86),2型双相情感障碍的合并1年患病率为0.50%(95%CI 0.35-0.64)。亚组分析显示,与DSM-III和DSM-IIIR标准相比,根据DSM-IV标准,1型双相情感障碍的终生患病率显著更高(p<0.001)。

结论

这项荟萃分析证实,1型和2型双相情感障碍在普通人群中的患病率估计较低。从DSM-III和DSM-III-R到DSM-IV患病率的增加可能反映了不同因素,如诊断操作的微小变化、使用不同的评估工具,甚至双相情感障碍患病率的真正增加。

相似文献

1
Bipolar disorder prevalence: a systematic review and meta-analysis of the literature.双相情感障碍患病率:文献的系统评价与荟萃分析
Braz J Psychiatry. 2015 Apr-Jun;37(2):155-61. doi: 10.1590/1516-4446-2012-1693. Epub 2015 May 1.
2
Lifetime prevalence of anxiety disorders in people with bipolar disorder: a systematic review and meta-analysis.双相情感障碍患者焦虑症的终生患病率:一项系统评价和荟萃分析。
Lancet Psychiatry. 2015 Aug;2(8):710-717. doi: 10.1016/S2215-0366(15)00112-1. Epub 2015 Jun 23.
3
Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) for the diagnosis of delirium in adults in critical care settings.**用于** ICU 成人患者的意识模糊评估方法(CAM-ICU)**用于** 诊断重症监护环境下成人的意识障碍。
Cochrane Database Syst Rev. 2023 Nov 21;11(11):CD013126. doi: 10.1002/14651858.CD013126.pub2.
4
Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults.氯胺酮及其他谷氨酸受体调节剂用于成人双相情感障碍的抑郁治疗
Cochrane Database Syst Rev. 2015 Sep 29(9):CD011611. doi: 10.1002/14651858.CD011611.pub2.
5
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.治疗师支持的针对成人焦虑症的互联网认知行为疗法。
Cochrane Database Syst Rev. 2016 Mar 12;3(3):CD011565. doi: 10.1002/14651858.CD011565.pub2.
8
Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.成人焦虑症的治疗师辅助互联网认知行为疗法。
Cochrane Database Syst Rev. 2015 Mar 5(3):CD011565. doi: 10.1002/14651858.CD011565.
9
Prevalence, impact and treatment of generalised anxiety disorder in bipolar disorder: a systematic review and meta-analysis.双相情感障碍中广泛性焦虑障碍的患病率、影响及治疗:一项系统评价与荟萃分析。
Evid Based Ment Health. 2016 Aug;19(3):73-81. doi: 10.1136/eb-2016-102412. Epub 2016 Jul 12.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.

引用本文的文献

1
Reducing the Delay in the Diagnosis of Bipolar Disorder: A Qualitative Study.减少双相情感障碍的诊断延迟:一项定性研究。
Health Expect. 2025 Aug;28(4):e70398. doi: 10.1111/hex.70398.
2
An observational study on gray matter volume and white matter integrity in suicide attempters with bipolar I disorder.一项关于双相I型障碍自杀未遂者灰质体积和白质完整性的观察性研究。
Indian J Psychiatry. 2025 Jun;67(6):615-621. doi: 10.4103/indianjpsychiatry_966_24. Epub 2025 Jun 11.
3
Cognitive insight and introspective accuracy in individuals with bipolar disorder: A scoping review.
双相情感障碍患者的认知洞察力和内省准确性:一项范围综述。
Neurosci Appl. 2023 Aug 19;2:101132. doi: 10.1016/j.nsa.2023.101132. eCollection 2023.
4
Knowledge, attitudes, and willingness of bipolar disorder patients toward electroconvulsive therapy: a cross-sectional study.双相情感障碍患者对电休克治疗的认知、态度及意愿:一项横断面研究。
Front Public Health. 2025 Jun 25;13:1572046. doi: 10.3389/fpubh.2025.1572046. eCollection 2025.
5
Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trial.普拉克索联合心境稳定剂治疗难治性双相抑郁:PAX - BD随机双盲安慰剂对照试验
Health Technol Assess. 2025 May;29(21):1-216. doi: 10.3310/HBFC1953.
6
Behavioral manifestations and underlying mechanisms of amphetamine in constructing animal models of mania: a comprehensive review.苯丙胺在构建躁狂症动物模型中的行为表现及潜在机制:综述
Front Neurosci. 2025 May 9;19:1544311. doi: 10.3389/fnins.2025.1544311. eCollection 2025.
7
Bipolar II disorder: a state-of-the-art review.双相II型障碍:最新综述
World Psychiatry. 2025 Jun;24(2):175-189. doi: 10.1002/wps.21300.
8
The Inaccuracy of the Mood Disorder Questionnaire for Bipolar Disorder in a Community Sample: From the "DYMERS" Construct Toward a New Instrument for Detecting Vulnerable Conditions.社区样本中双相情感障碍心境障碍问卷的不准确之处:从“DYMERS”结构到一种检测易患状况的新工具。
J Clin Med. 2025 Apr 27;14(9):3017. doi: 10.3390/jcm14093017.
9
The effect of systematic antidepressant treatments in the early stages on sleep and impulsivity in bipolar euthymic patients: A cross-sectional study.双相情感障碍心境正常患者早期系统性抗抑郁治疗对睡眠和冲动性的影响:一项横断面研究。
PLoS One. 2025 Apr 29;20(4):e0322274. doi: 10.1371/journal.pone.0322274. eCollection 2025.
10
Characterization of the Molecular Mechanisms Underlying Lurasidone-Induced Acute Manic Episodes in Bipolar Depression: A Network Pharmacology and Molecular Docking Approach.鲁拉西酮诱发双相抑郁症急性躁狂发作的分子机制表征:一种网络药理学和分子对接方法。
CNS Neurosci Ther. 2025 Apr;31(4):e70383. doi: 10.1111/cns.70383.